Medical doctor from the Federal University of Bahia (2009), with a master’s in Health Biotechnology and Investigative Medicine from Fiocruz (2012) and a PhD in Human Pathology from UFBA (2016). He was a visiting researcher at the San Raffaele Scientific Institute in Milan (2010–2011) and at the Innovative Genomics Institute of the University of California, Berkeley (2023–2024). He is a researcher in Public Health at the Gonçalo Moniz Institute (Fiocruz-BA) and a researcher at Instituto D’Or de Pesquisa e Ensino (IDOR) / Pioneer Science. He is a CNPq research productivity fellow and an affiliated member of the Brazilian Academy of Sciences. He works in clinical and translational research in advanced therapies, focusing on cell therapy, regenerative medicine, and CRISPR-based gene editing.
